Public Law 115 - 52 - FDA Reauthorization Act of 2017 - PLAW-115publ52 | Content Details

Public Law 115 - 52 - FDA Reauthorization Act of 2017

Full Title: An act to amend the Federal Food, Drug, and Cosmetic Act to revise and extend the user-fee programs for prescription drugs, medical devices, generic drugs, and biosimilar biological products, and for other purposes.

Statutes at Large Citations: 131 Stat. 1005, 1006, 1007, 1008, 1009, 1010, 1011, 1012, 1013, 1014, 1015, 1016, 1017, 1018, 1019, 1020, 1021, 1022, 1023, 1024, 1025, 1026, 1027, 1028, 1029, 1030, 1031, 1032, 1033, 1034, 1035, 1036, 1037, 1038, 1039, 1040, 1041, 1042, 1043, 1044, 1045, 1046, 1047, 1048, 1049, 1050, 1051, 1052, 1053, 1054, 1055, 1056, 1057, 1058, 1059, 1060, 1061, 1062, 1063, 1064, 1065, 1066, 1067, 1068, 1069, 1070, 1071, 1072, 1073, 1074, 1075, 1076, 1077, 1078, 1079, 1080, 1081, 1082, 1083, 1084, 1085, 1086, 1087, 1088, 1089 and 1090

United States Code Citations: 5 U.S.C. 552 and 552a
18 U.S.C. 1905
21 U.S.C. 321, 321, 333, 351, 355, 355-1, 355a, 355c, 355c-1, 355d, 355g, 356e, 356g, 360, 360bb, 360bbb, 360bbb-0, 360bbb-5, 360bbb-8c, 360c, 360cc, 360d, 360e, 360e-1, 360e-3, 360ee, 360i, 360j, 360m, 360n, 374, 379d-3, 379f, 379g, 379h, 379h-2, 379i, 379j, 379j-1, 379j-12, 379j-41, 379j-42, 379j-43, 379j-51, 379j-52, 379j-53, 379k-1, 381, 384e, 393a, 739i and 739j-1
42 U.S.C. 1320d-2, 262, 282, 284m and 360j

Legislative History: LEGISLATIVE HISTORY--H.R. 2430 (S. 934):

HOUSE REPORTS: No. 115-201 (Comm. on Energy and Commerce).
CONGRESSIONAL RECORD, Vol. 163 (2017):
July 12, considered and passed House.
Aug. 3, considered and passed Senate.